88747
document
Durability of central venous catheters . A randomized trial in children with malignant diseases . In a prospective randomized study the durability of tunnelled and non-tunnelled central venous catheters was investigated in children with malignant diseases . Twenty children were included in the study but four ( two in each group ) had to be excluded ; three because the entry criteria turned out not to be fulfilled and one because of lack of data . The median duration of the tunnelled catheters was 224 days with a range of 25-846 days which was significantly longer than that of conventional catheters ( 39.5 days , range 9-228 days ) . In addition six of eight conventional catheters were accidentally removed whereas all catheters in the tunnelled group had to be removed via a small incision . Three cases of catheter related sepsis , two in the tunnelled group and one in the conventional group , were registered . The corresponding number of infections per catheter days were 1 in 1189 days and 1 in 522 days , respectively . In conclusion cuffed , tunnelled central venous catheters are less prone to displacement than traditional percutaneous central venous catheters when used in children with malignant diseases .
88748
Intervention_Physical
central venous catheters
88749
Intervention_Physical
tunnelled and non-tunnelled central venous catheters
88750
Intervention_Physical
tunnelled catheters
88751
Intervention_Physical
conventional catheters
88752
Intervention_Physical
cuffed , tunnelled central venous catheters
88753
Intervention_Physical
traditional percutaneous central venous catheters
88754
Outcome_Other
Durability
88755
Outcome_Other
durability
88756
Outcome_Other
median duration
88757
Outcome_Other
significantly longer
88758
Outcome_Adverse-effects
catheter related sepsis
88759
Outcome_Adverse-effects
number of infections per catheter days
88760
Outcome_Other
displacement
88761
Participant_Age
children
88762
Participant_Condition
with malignant diseases .
88763
Participant_Age
children
88764
Participant_Condition
with malignant diseases .
88765
Participant_Sample-size
Twenty
88766
Participant_Sample-size
four
88767
Participant_Sample-size
two
88768
Participant_Sample-size
three
88769
Participant_Sample-size
one
88770
Participant_Condition
malignant diseases